The Beneficial Biological Properties of Salicylic Acid

Open access


Salicylic acid is a phytochemical with beneficial effects on human well-being. Salicylic acid is a phenolic compound and is present in various plants where it has a vital role in protection against pathogenic agents. Natural sources include fruits, vegetables and spices. The most famous and defined effect of salicylic acid is prostaglandin synthesis inhibition. Salicylic acid has antiinflammatory effects through suppression of transcription of genes for cyclooxygenase. Most of the pharmacological properties of salicylic acid can be contributed to the inhibition of prostaglandin synthesis. Also, it was discovered that salicylic acid has other in vivo cyclooxygenase-independent pathways. Since salicylic acid does not inhibit cyclooxygenase considerably, the anti-inflammatory effect is not a consequence of direct inhibition of cyclooxygenase activity. Because of its fundamental role, it was suggested that inhibition of nuclear factor kappa B by salicylic acid is one of the key anti-inflammatory mechanisms of action for salicylates. One of the most studied properties of salicylic acid is its antioxidative activity. Salicylic acid is a confirmed inhibitor of oxidative stress. Salicylic acid is capable of binding iron. This fact is significant for antioxidative effect of salicylic acid because iron has an important function in the course of lipid peroxidation.

1. Dempsey DA, Klessing DF. Salicylic acid, active oxygen species and system acquired resistance in plants. Trends Cell Biol 1994; 4:334-8.

2.Dangl J. Innate immunity.Plant just say NO to pathogens. Nature 1998; 394:525-7.

3. Stanley P, Hegedus R. Aspirin - the first hundred years. Biologist 2000; 47: 269-71.

4. Sanmuganathan PS, Ghahramani P, Jackson PRet al. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart 2001; 85: 265-71.

5. Gasche C. Review Article: The chemoprevention of colorectal carcinoma. Aliment Pharmacol Ther 2004; 20: 31-35.

6. Duthie GG, Wood AD.Natural salicylates: foods, functions and disease prevention. Food Funct 2011; 2:515-520.

7. Schindler PE Jr, Fields WS. Aspirin Therapy. Walker and Company,New York, 1978.

8. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231:232-235.

9. Murray RK, Granner DK, Mayes PA, Rodwell VW. Harper's Biochemistry.21st edn.Appleton & Lange, Norwalk, 1988.

10. Ohki S, Ogino N, Yamamoto S, Hayaishi O. Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxidesynthetase from bovine vesicular gland microsomes. J Biol Chem 1979; 254:829-36.

11. Xu XM, Sansores-Garcia L, Chen XM, Matijevic- Aleksic N, Du M, Wu KK.Suppression of inducible cyclooxygenases-2 gene transcription by aspirin and sodium salicylate. Proc Natl Acad Sci USA 1999; 96:5292-5297.

12. Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 2001; 15:2057-2072.

13. Abramson SB, Leszczynska-Piziak J, Clancy RM, Philips M, Weissmann G. Inhibition of neutrophil function by aspirin-like drugs (NSAIDS): requirement for assembly of heterotrimeric G proteins in bilayer phospholipid. Biochem Pharmacol 1994; 47:563-572.

14. Abramson SB, Weissmann G. The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1989; 32:1.

15. Aeberhard EE, Henderson SA, Arabolos NS et al. Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem Biophys Res Commun 1995; 208:1053-1059.

16. Kepka-Lenhart D, Chen LC, Morris SM. Novel actions of aspirin and sodium salicylate: discordant effects on nitric oxide synthesis and induction of nitric oxide synthase mRNA in a murine macrophage cell line. J Leukoc Biol 1996; 59:840-6.

17.Ryu YS, Lee JH, Seok JH et al. Acetaminophen inhibits iNOS gene expression in RAW 264.7 macrophages: differential regulation of NFkappaB by acetaminophen and salicylates. Biochem Biophys Res Commun 2000; 272:758-64.

18. Sakitani K, Kitade H, Inoue K et al. The antiinflammatory drug sodium salicylate inhibits nitric oxide formation induced by interleukin-1beta at a translational step, but not at a transcriptional step, in hepatocytes. Hepatology 1997; 25:416-420.

19.Chung CK, Koo HN, Chung KY et al. Inhibitory effect of sodium salicylate on nitric oxide production from TM4 sertoli cells.Int J Immunopharmacol 2000; 22:685-692.

20. Nishio E, Watanabe Y. Aspirin and salicylate enhances the induction of inducible nitric oxide synthase in cultured rat smooth muscle cells. Life Sci 1998; 63:429-439.

21. Cronstein BN, Montesinos MC, Weissmann G. Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkB. Proc Natl Acad Sci USA 1999; 96:6377-6381.

22. Catania A, Arnold J, Macaluso A, Hiltz ME, Lipton JM. Proc Natl Acad Sci USA 1991; 88:8544-8547.

23. Randjelovic P, Veljkovic S, Stojiljkovic N et al. Salicylic acid attenuates gentamicin-induced nephrotoxicity in rats. Scientific World Journal 2012; 2012:390613.

24. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994; 265:956-9.

25. Yin MJ, Yamamoto Y, Gaynor RB. The antiinflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 1998; 396:77-80.

26. Bayon Y, A lonso A , S anchez C respo M . 4 - Trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4- trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation. Br J Pharmacol 1999; 126:1359-66.

27. Pahl HL. Activators and target genes of Rel/NFkappaB transcription factors. Oncogene1999; 18:6853-66.

28. Cianferoni A, Schroeder JT, Kim J et al. Selective inhibition of interleukin-4 gene expression in human T cells by aspirin. Blood 2001; 97:1742-1749.

29. Colantoni A, de Maria N, Caraceni P, Bernardi M, Floyd RA, Van Thiel DH. Prevention of reoxygenation injury by sodium salicylate in isolated-perfused rat liver. Free Radic Biol Med 1998; 25:87-94.

30. Pillinger MH, Capodici C, Rosenthal P et al. Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion. Proc Natl Acad Sci U.S.A 1998; 95:14540-14545.

31. Aceves M, Duenas A, Gomez C, San Vicente E, Crespo MS, Garcia-Rodriguez C. A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription. J Immunol 2004; 173:5721-5729.

32. Sagone AL Jr, Husney RM. Oxidation of salicylates by stimulated granulocytes: evidence that these drugs act as free radical scavengers in biological systems. J Immunol 1987; 138:2177-83.

33. Dragomir E, Manduteanu I, Voinea M, et al. Aspirin rectifies calcium homeostasis, decreases reactive oxygen species, and increases NO production in high glucose-exposed human endothelial cells. J Diabetes Complications 2004; 18:289-99.

34. Kotrly S, Sucha L. Handbook of Chemical Equilibria in Analytical Chemistry. Ellis Horwood Limited, Chichester, 1985.

35. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: an overview. In: Packer L, Glazer AN (eds), Methods Enzymol, vol. 186. Academic Press, California, 1990: 1-5.

Acta Facultatis Medicae Naissensis

The Journal of Faculty of Medicine in Nis

Journal Information

Cite Score 2018: 0.33

SCImago Journal Rank (SJR) 2018: 0.134
Source Normalized Impact per Paper (SNIP) 2018: 0.287

Cited By


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 729 598 41
PDF Downloads 302 268 21